Literature DB >> 20399786

The role of TNF in parasitic diseases: still more questions than answers.

Heinrich Körner1, Brendan McMorran, Dirk Schlüter, Phillip Fromm.   

Abstract

The inhibition of TNF with therapeutic monoclonal antibodies or antibody/receptor fusion proteins in rheumatoid arthritis still constitutes the benchmark for a successful intervention in an ongoing auto-immune-inflammatory disease and underlines the importance of this cytokine. TNF plays a central role in the defence against intracellular infections and is responsible for the promotion of different aspects of the innate immune response such as inflammatory cell recruitment and cell differentiation. While this cytokine generally displays pro-inflammatory activities supporting the early stages of the inflammatory response, it has been demonstrated to be especially important during infection with intracellular pathogens and, consequently, leishmaniasis of TNF(-/-) mice ends fatally. However, the specific activities of TNF that confer protection are not yet fully understood. This review will summarize the current understanding of TNF function and signalling, and will discuss recent work in the models of malaria, toxoplasmosis, trypanosomiasis and leishmaniasis with particular emphasis on work with gene-deficient mouse models. 2010 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20399786     DOI: 10.1016/j.ijpara.2010.03.011

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  15 in total

Review 1.  Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets.

Authors:  Pauline L Martin; Peter J Bugelski
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

2.  CD47-SIRPα Interactions Regulate Macrophage Uptake of Plasmodium falciparum-Infected Erythrocytes and Clearance of Malaria In Vivo.

Authors:  Kodjo Ayi; Ziyue Lu; Lena Serghides; Jenny M Ho; Constance Finney; Jean C Y Wang; W Conrad Liles; Kevin C Kain
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

3.  Toxoplasma gondii: bystander or cofactor in rheumatoid arthritis.

Authors:  Svetlana Fischer; Nancy Agmon-Levin; Yinon Shapira; Bat-Sheva Porat Katz; Eduard Graell; Ricard Cervera; Ljudmila Stojanovich; Jose A Gómez Puerta; Raimon Sanmartí; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

4.  TNF-Mediated Restriction of Arginase 1 Expression in Myeloid Cells Triggers Type 2 NO Synthase Activity at the Site of Infection.

Authors:  Ulrike Schleicher; Katrin Paduch; Andrea Debus; Stephanie Obermeyer; Till König; Jessica C Kling; Eliana Ribechini; Diana Dudziak; Dimitrios Mougiakakos; Peter J Murray; Renato Ostuni; Heinrich Körner; Christian Bogdan
Journal:  Cell Rep       Date:  2016-04-21       Impact factor: 9.423

Review 5.  IgE and mast cells in host defense against parasites and venoms.

Authors:  Philipp Starkl; Thomas Marichal; Kaori Mukai; Mindy Tsai; Stephen J Galli
Journal:  Semin Immunopathol       Date:  2016-05-25       Impact factor: 9.623

Review 6.  Using two phases of the CD4 T cell response to blood-stage murine malaria to understand regulation of systemic immunity and placental pathology in Plasmodium falciparum infection.

Authors:  Komi Gbedande; Victor H Carpio; Robin Stephens
Journal:  Immunol Rev       Date:  2020-01       Impact factor: 12.988

7.  Interferon-γ, a valuable surrogate marker of Plasmodium falciparum pre-erythrocytic stages protective immunity.

Authors:  Blanca-Liliana Perlaza; Jean-Pierre Sauzet; Karima Brahimi; Lbachir BenMohamed; Pierre Druilhe
Journal:  Malar J       Date:  2011-02-08       Impact factor: 2.979

8.  Intermittent preventive treatment with sulfadoxine-pyrimethamine does not modify plasma cytokines and chemokines or intracellular cytokine responses to Plasmodium falciparum in Mozambican children.

Authors:  Diana Quelhas; Laura Puyol; Llorenç Quintó; Tacilta Nhampossa; Elisa Serra-Casas; Eusébio Macete; Pedro Aide; Sergi Sanz; John J Aponte; Denise L Doolan; Pedro L Alonso; Clara Menéndez; Carlota Dobaño
Journal:  BMC Immunol       Date:  2012-01-26       Impact factor: 3.615

9.  Deficiency of Leishmania phosphoglycans influences the magnitude but does not affect the quality of secondary (memory) anti-Leishmania immunity.

Authors:  Dong Liu; Ifeoma Okwor; Zhirong Mou; Stephen M Beverley; Jude E Uzonna
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

10.  Fatal Leishmaniasis in the Absence of TNF Despite a Strong Th1 Response.

Authors:  Phillip D Fromm; Jessica C Kling; Annika Remke; Christian Bogdan; Heinrich Körner
Journal:  Front Microbiol       Date:  2016-01-22       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.